Mankind Pharma Limited (BOM:543904)
India · Delayed Price · Currency is INR 2,485.20
+5.25 (0.21%)
At close: Oct 6, 2026
Mankind Pharma Market Cap
Mankind Pharma has a market cap or net worth of 1.03 trillion as of October 7, 2026. Its market cap has increased by 2.18% in one year.
Market Cap
1.03T
Enterprise Value
1.08T
Revenue
147.38B
Ranking
n/a
PE Ratio
50.55
Stock Price
2,485.20
ChartMarket Cap Chart
Since May 9, 2023, Mankind Pharma's market cap has increased from 569.76B to 1.03T, an increase of 81.22%. That is a compound annual growth rate of 19.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 1.03T | 13.87% |
| Dec 31, 2025 | 906.73B | -23.70% |
| Dec 31, 2024 | 1.19T | 49.64% |
| Dec 29, 2023 | 794.17B | 39.39% |
| May 9, 2023 | 569.76B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.81T |
| Dr. Reddy's Laboratories | 999.66B |
| Lupin | 919.04B |
| Abbott India | 570.16B |
| GlaxoSmithKline Pharmaceuticals | 470.02B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Granules India | 203.39B |
| Caplin Point Laboratories | 200.09B |